Antiulcer properties of glycyrrhiza glabra L. Extract on experimental models of gastric ulcer in mice

Iranian Journal of Pharmaceutical Research

Volumn 14, Issue 4, 2015, Pages 1163-1170

  Jalilzadeh Amin, Ghader ^a   Najarnezhad, Vahid ^a   Anassori, Ehsan ^a   Mostafavi, Mostafa ^a   Keshipour, Hadi ^a  

^a URMIA UNIVERSITY   (Iran)

Author keywords

Ethanol; Glycyrrhiza glabra L; Indomethacin; Peptic ulcer; Stress

Indexed keywords

CIMETIDINE; GLYCYRRHIZA GLABRA EXTRACT; OMEPRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIULCER ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; EDEMA; FEMALE; GASTRIC MUCOSA; HYPEREMIA; LD50; MALE; MOUSE; MUCOSAL BLEEDING; NONHUMAN; PETECHIA; SCORING SYSTEM; STEREOMICROSCOPY; STOMACH ULCER; STRESS ULCER; ULCERATION INDEX;

EID: 84965020834     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Tian M, Yan H, and Row KH. Extraction of Glycyrrhizic Acid and Glabridin from Licorice. Int. J. Mol. Sci. (2008) 9: 7.
2. Farina C, Pinza M, and Pifferi G. Synthesis and anti-ulcer activity of new derivatives of glycyrrhetic,oleanolic and ursolic acids. 11 Farrnaco (1998) 53: 22-23.
3. Wittschiera N, Faller G, and Hensela A. Aqueous extracts and polysaccharides from Liquorice roots (Glycyrrhiza glabra L.) inhibit adhesion of Helicobacter pylori to human gastric mucosa. J. Ethnopharmacol. (2009) 125: 218-223.
4. Dhingra D, Parle M, and Kulkarni S. Memory enhancing activity of Glycyrrhiza glabra in mice. J. Ethnopharmacol. (2004) 91: 361-365.
5. Klein LC Jr., Gandolfi RB, Santin JR, Lemos M, Cechinel Filho V, de And rade SF. Antiulcerogenic activity of extract, fractions, and some compounds obtained from Polygala cyparissias St. Hillaire & Moquin (Polygalaceae). Naunyn-Schmied Arch Pharmacol. (2010) 381:121-126.
6. Asadipoura A, Edrakib N, Nakhjirib M, Yahya-Meymandib A, Alipourd E, Sanieee P, Siavoshie F, Shafieea A, and Foroumadi A. Anti-Helicobacter pylori activity and Structure-Activity Relationship study of 2-Alkylthio-5-(nitroaryl)-1,3,4-thiadiazole Derivatives. Iran. J. Pharm. Res. (2013) 12(3): 7.
7. Gohar AA, and Zaki AA. Assessment of some Herbal Drugs for Prophylaxis of Peptic Ulcer. Iran. J. Pharm. Res. (2014) 13(3):6.
8. D. Lorke. A new approach to practical acute toxicity testing. Arch. Toxicol. (1983) 54:275-287.
9. Meyer Albiero AL, Aboin Sertié JA, and Bacchi EM. Antiulcer activity of Sapindus saponaria L. in the rat. J. Ethnopharmacol. (2002) 82:41-44.
10. Basile AC, Sertié JA, Panizza S, Oshiro TT, and Azzolini CA. Pharmacological assay of Casearia sylvestrisz. I: Preventive anti-ulcer activity and toxicity of the leaf crude extract. J Ethnopharmacol. (1990) 30: 185-187.
11. Santos Cerqueira G,1 dos Santos e Silva G, Rios Vasconcelos E, Fragoso de Freitas AP, Arcanjo Moura B, Silveira Macedo D, Lopes Souto A, Barbosa Filho JM, de Almeida Leal LK, de Castro Brito GA, Souccar C, and de Barros Viana GS. Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice. Eur. J. Pharmacol. (2012) 683: 260-269.
12. Sairam K, Priyambada S, Aryya NC, and Goel RK. Gastroduodenal ulcer protective activity of Asparagus racemosus: an experimental, biochemical and histological study. J. Ethnopharmacol. (2003) 86: 1-10.
13. Santin JR,1 Lemos M, Klein-Júnior LC, Machado ID, Costa P, de Oliveira AP, Tilia C, de Souza JP, de Sousa JP, Bastos JK, and de Andrade SF. Gastroprotective activity of essential oil of the Syzygium aromaticum and its major component eugenol in different animal models. Naunyn-Schmied. Arch. Pharmacol. (2011) 383: 149-158.
14. Borrelli F, and Izzo AA. The plant kingdom as a source of antiulcer remedies. Phytother. Res. (2000) 14: 581-591.
15. Morrision J, Quiton R, and Reinert H. The purpose and value of LD50 determinations. In: Boyland E. and Goulding R. (eds.) Modern trends in toxicology. Butterworths, London (1968)1-17.
16. Isbrucker RA and Burdock GA. Risk and safety assessment on the consumption of licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul. Toxicol. Pharmacol. (2006) 46: 167-192.
17. Y, M., et al. Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine. Jap. J. Pharmacol. (1991) 57: 495-505.
18. Morimoto Y, Shimohara K, Oshima S and Sukamoto T. Gastric antiulcer and cytoprotective effect of Commiphora molmol in rats. J. Ethnopharmacol. (1997) 55: 141-150.
19. Kinoshita M, Noto T, and Tamaki H. Effect of a combination of ecabet sodium and cimetidine on experimentally induced gastric lesions and gastric mucosal resistance to ulcerogenic agents in rats. Biol. Pharm. Bull. (1995) 18:223-226.
20. Takeeda M, Hayashi Y, Yamato M, Murakami M and Takeuchi K. Roles of endogenous prostaglandins and cyclooxygenase isozymes in mucosal defense of inflamed rat stomach. J. Physiol. Pharmacol. (2004) 55: 193-205.
21. Laine L, Takeuchi K, and Tarnawski A. Reviews in basic and clinical gastroenterology. Gastroenterol. (2008) 135: 41-60.
22. Vedavyasa S. Gastric mucosal cellular changes induced by indomethacin male albino rats. Indian. J. Exp. Biol. (1999) 37: 365-369.
23. Baker ME. Licorice and enzymes other than 11 betahydroxysteroid dehydrogenase: an evolutionary perspective. Steroids. (1994) 59: 136-141.
24. Bjarnason I, Scarpignato C, Takeuchi K and Rainsford KD. Determinants of the short-term gastric damage caused by NSAIDs in man. Aliment. Pharmacol. Ther. (2007) 26: 95-106.
25. Sairam K, Rao VC, Babu DM, and Goel RK. Prophylactic and curative effects of Bacopa monniera in gastric ulcer models. Phytomedicine. (2001) 8: 423-430.
26. Gumpricht E, Dahl R, Devereaux MW, and Sokol RJ. Licorice compounds glycyrrhizin and 18beta-glycyrrhetinic acid are potent modulators of bile acid-induced cytotoxicity in rat hepatocytes. J. Biol. Chem. (2005) 280: 10556-10563.
27. Kang JS, Yoon YD, Cho IJ, Han MH, Lee CW, Park SK, and Kim HM. Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock. J. Pharmacol. Exp. Ther. (2005) 312: 1187-1194.
28. Rosenblat M, Colman R, and Aviram M. Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. (2002) 163:17-28.
29. Nassiri M and Hosseinzadeh H. Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds. Phytother. Res. (2008) 22: 709-724.
30. Di Mambro VM, and Fonseca MJV. Assays of physical stability and antioxidant activity of a topical formulation added with different plant extracts. J Pharm. Biomed. Anal. (2005) 37:287-295.
31. Hodek P, Trefil P, and Stiborová M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem. Biol. Interact. (2002) 139:1-21.
32. Motilva V, Alarcon De La Lastra C, and Calero MJM. Effects of naringenin and quercetin on experimental chronic gastric ulcer in rat studies on the histological findings. Phytother. Res. (1992) 6:168-170.
33. Aly AM, Al-Alousi L, and Salem HA. Licorice: A possible anti-inflammatory and anti-ulcer drug. AAPS Pharm. Sci. Tech. (2005) 6: E74-E82.
34. Suzuki Y, Ishihara M, Segami T, and Ito M. Anti-ulcer effects of antioxidants, quercetin, alpha-tocopherol, nifedipine and tetracycline in rats. Jap. J. Pharmacol. (1998) 78:435-441.
35. Xiao M, Yang Z, Jiu M, You J, and Xiao R. The anti-gastroulcerative activity of beta-sitosterol-beta-d-glucoside and its aglycone in rats. Hua Xi Yi Ke Da Xue Xue Bao. (1992) 23:98-101.